» Articles » PMID: 29977483

Acral Myxoinflammatory Fibroblastic Sarcoma with Hybrid Features of Hemosiderotic Fibrolipomatous Tumor Occurring 10 years After Renal Transplantation

Overview
Journal Rare Tumors
Publisher Sage Publications
Specialty Oncology
Date 2018 Jul 7
PMID 29977483
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Myxoinflammatory fibroblastic sarcoma is a rare malignant soft tissue neoplasm that typically arises on the distal extremities of adults. It usually behaves in a low-grade manner and its characteristic histology is of a lobulated proliferation of moderately atypical spindled to epithelioid cells, vacuolated cells, and enlarged or bizarre cells with prominent nucleoli, dispersed within myxoid stroma containing a mixed inflammatory cell infiltrate. The etiology of myxoinflammatory fibroblastic sarcoma remains unknown with no definite causal factors identified. We describe a case of myxoinflammatory fibroblastic sarcoma arising in the foot of a 77-year-old female, which rapidly recurred locally after initial excision and which arose 10 years after renal transplantation. The neoplasm also showed intermingled areas of hemosiderotic fibrolipomatous tumor. The patient also had multifocal areas of squamous cell carcinoma in situ of the foot and hand, in keeping with the clinical context of immune deficiency. This is the second case of myxoinflammatory fibroblastic sarcoma reported to occur after transplantation, but additionally shows hybrid features of hemosiderotic fibrolipomatous tumor, highlights immunocompromise/immunosuppressive therapy as a possible etiologic factor in their development, and adds to the growing number of myxoinflammatory fibroblastic sarcoma that has demonstrated aggressive behavior.

Citing Articles

Report of two cases of myxoinflammatory fibroblastic sarcomas with preceding hematolymphoid neoplasms: Is there any association?.

Aminparast Z, Sadeghi M, Ramezani M Clin Case Rep. 2022; 10(7):e6065.

PMID: 35865776 PMC: 9291260. DOI: 10.1002/ccr3.6065.

References
1.
Carter J, Sukov W, Montgomery E, Goldblum J, Billings S, Fritchie K . TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms. Am J Surg Pathol. 2014; 38(9):1182-992. DOI: 10.1097/PAS.0000000000000212. View

2.
Lombardi R, Jovine E, Zanini N, Salone M, Gambarotti M, Righi A . A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases. Int Orthop. 2013; 37(12):2429-36. PMC: 3843193. DOI: 10.1007/s00264-013-2048-5. View

3.
Fanburg-Smith J . Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle. Mod Pathol. 2000; 13(11):1192-9. DOI: 10.1038/modpathol.3880221. View

4.
Laskin W, Fetsch J, Miettinen M . Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome. Am J Surg Pathol. 2013; 38(1):1-12. PMC: 7670880. DOI: 10.1097/PAS.0b013e31829f3d85. View

5.
Lambert I, Debiec-Rychter M, Guelinckx P, Hagemeijer A, Sciot R . Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes. Virchows Arch. 2001; 438(5):509-12. DOI: 10.1007/s004280000376. View